Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer

Published:2017-10-13 Issue:2 Volume:194 Page:79-90
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Käsmann Lukas, ,Niyazi Maximilian,Blanck Oliver,Baues Christian,Baumann René,Dobiasch Sophie,Eze Chukwuka,Fleischmann Daniel,Gauer Tobias,Giordano Frank A.,Goy Yvonne,Hausmann Jan,Henkenberens Christoph,Kaul David,Klook Lisa,Krug David,Mäurer Matthias,Panje Cédric M.,Rosenbrock Johannes,Sautter Lisa,Schmitt Daniela,Süß Christoph,Thieme Alexander H.,Trommer-Nestler Maike,Ziegler Sonia,Ebert Nadja,Medenwald Daniel,Ostheimer Christian

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s00066-017-1221-y/fulltext.html

Reference45 articles.

1. Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2:706–714

2. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics 2016. CA Cancer J Clin 66:7–30

3. Bosmans G, van Baardwijk A, Dekker A et al (2006) Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 66:748–753

4. Fox J, Ford E, Redmond K et al (2009) Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 74:341–348

5. Agrawal V, Coroller TP, Hou Y et al (2016) Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC. Lung Cancer 102:1–8

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of primary tumor volume change during concurrent chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer;Radiotherapy and Oncology;2024-09

2. First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis;Strahlentherapie und Onkologie;2023-11-17

3. Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma;Clinical Lung Cancer;2023-05

4. Development and Validation of Prognostic Nomograms for Lung Squamous Cell Carcinoma With Brain Metastasis in Patients Aged 45 Years or Older: A Population-Based Study;Cancer Control;2023-04

5. Use of durvalumab in stage III non‐small‐cell lung cancer based on eligibility for the PACIFIC study;Thoracic Cancer;2023-01-10